Lagura, Wilhelmina B.

HRN: 27-82-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2025
CEFTRIAXONE 1G (VIAL)
09/19/2025
09/26/2025
IV
2g
OD
CAP MR
Checking Initial Appropriateness 
09/19/2025
AZITHROMYCIN 500MG TABLET (TAB)
09/19/2025
09/26/2025
PO
500
OD
CAP MR
Checking Initial Appropriateness 
09/24/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/24/2025
10/01/2025
IV
2.25mg
Q6
CAP Non Resolve
Checking Initial Appropriateness 
09/30/2025
LEVOFLOXACIN 500MG (TAB)
09/30/2025
10/07/2025
ORAL
500mg
Every Other Day
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: